status of compounded tirzepatide Tirzepatide: A Dual-Action Peptide Compounded Tirzepatide | KEWW Primary
Description
Fatigue tends to show up most often during the first few weeks of treatment or shortly after a dose increase, when the body is adapting to changes in appetite, digestion, and metabolism

They can also identify early signs of lipohypertrophy and recommend appropriate management

Most parts of Colorado do not have such a system, making it hard to replicate the DHMC system statewide

Never refrigerate oral tirzepatide tablets unless specifically instructed by PlexusDx or your pharmacist, as excessive cold and condensation from temperature changes can cause breakdown of the compounded formulation

Before starting stimulant therapy, a baseline cardiovascular assessment including blood pressure and pulse is recommended, with ongoing monitoring during treatment
